Request Demo
Last update 14 Mar 2026
The Second Affiliated Hospital of Guangxi University of Chinese Medicine (Guangxi Integrated Traditional and Western Medicine Hospital)
Hospital|Guangxi Zhuangzu Zizhiqu, China
Hospital|Guangxi Zhuangzu Zizhiqu, China
Last update 14 Mar 2026
Overview
Tags
Respiratory Diseases
Infectious Diseases
Herbal medicine
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
No Data
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
CTR20255066
评价止得咳颗粒对急性气管-支气管炎（风热犯肺证）的患者有效性及安全性的双盲、随机、多中心、安慰剂对照Ⅱ期临床试验
[Translation] A double-blind, randomized, multicenter, placebo-controlled phase II clinical trial evaluating the efficacy and safety of Zhide Ke Granules in patients with acute tracheobronchitis (wind-heat invading the lungs syndrome).
ChiCTR2300069338
Discussion on Pathogenic Mechanism of Intestinal Flora and Metabolic Network Crosstalk in MHE and Intervention Effect of Rhubarb Decoction
ChiCTR2300070958
Observation on the efficacy of Olotadine Hydrochloride combined with ebastine in the treatment of chronic eczema And its effect on serum IgE and IL-6 levels
100 Clinical Results associated with The Second Affiliated Hospital of Guangxi University of Chinese Medicine (Guangxi Integrated Traditional and Western Medicine Hospital)
Login to view more data
Login to view more data
100 Deals associated with The Second Affiliated Hospital of Guangxi University of Chinese Medicine (Guangxi Integrated Traditional and Western Medicine Hospital)
Login to view more data
100 Translational Medicine associated with The Second Affiliated Hospital of Guangxi University of Chinese Medicine (Guangxi Integrated Traditional and Western Medicine Hospital)
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 19 Mar 2026
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 2
1
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free